Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Bempedoic Acid + Ezetimibe, Atc C10ba10 For The Period 03/01/2023 - 02/28/2025

DAK-GESUNDHEIT Germany has Released a tender for Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Bempedoic Acid + Ezetimibe, Atc C10ba10 For The Period 03/01/2023 - 02/28/2025 in Pharmaceuticals. The tender was released on Jan 21, 2023.

Country - Germany

Summary - Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Bempedoic Acid + Ezetimibe, Atc C10ba10 For The Period 03/01/2023 - 02/28/2025

Deadline - Jan 05, 2025

MT reference number - 11199531

Product classification - Medical solutions

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 11199531

  Document Type - Tender Notices

Notice Details and Documents:

Description - Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v for the active ingredient bempedoic acid + ezetimibe, atc c10ba10 for the period 03/01/2023 - 02/28/2025§ 130a paragraph 8 sgb v enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be dispensed at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the dak health. for medicinal products to be s

Mt Ref Id - 11199531

Deadline - Jan 05, 2025

Share

Similar Tenders :